top of page
ai in medicine, ai diagnosis, artificial intelligence medical diagnosis, ai medical diagnosis, ai medical, artificial intelligence medical, medical diagnosis ai, ai for medical diagnosis, ai medical research, artificial intelligence medical research, ai in clinical trial, ai in clinical trials, ai for clinical trials, ai disease diagnosis, ai disease detection, ai diagnostics, ai diagnosis healthcare, ai healthcare diagnosis, ai for medical, ai for mental health, ai and dementia, ai healthcare research, ai technology in medicine, ai in medical diagnostics, ai diagnosis in healthcare, ai to diagnose mental illness, ai assisted medical diagnosis, medical diagnosis using ai, ai to detect alzheimer's, ai dementia diagnosis, ai for dementia, ai to detect alzheimer's disease, ai mental healthcare, ai for early disease detection, ai in clinical research, ai for depression, ai and psychiatry, ai for medicine, ai research for clinical trials,
cough drug, chronic cough, respiratory monitoring, respiration monitors, respiratory monitor, respiratory monitoring devices, respiratory sensors, respiratory monitoring system, non-invasive respiratory monitoring, respiratory function monitor, portable respiratory monitor, cough detection, peak cough flow meter, peak cough flow measurement, cough detector, cough intensity, cough pattern, cough recorder, cough recording, cough studies, ai cough monitor, continuous cough measurement, cough data, cough measurement, cough measurement device, cough measurement system, cough measuring device, cough monitor, cough monitoring device, cough monitoring system, cough peak flow measurement, cough profile, cough tracker, coughtracker, detect and quantify cough, remote patient monitoring copd, copd remote monitoring, copd home monitoring, copd remote patient monitoring,

Enhancing care for respiratory patients with continuous cough monitoring

Medical Device CE Mark

ABOUT US

We leverage our pharmaceutical heritage and Swiss quality to provide innovative solutions in respiratory health to improve patients' lives. We collaborate with global healthcare companies, researchers, and clinics to advance the field by using novel, sound-based digital biomarkers.​

biomarkers depression, biomarker analysis, biomarkers in depression, biomarker depression, biomarkers analysis, biomarkers for depression, biomarkers of depression, depression biomarkers, depression biomarker, clinical biomarker, biomarker in medicine, biomarkers in medicine, biomarkers of dementia, biomarkers dementia, biomarkers for dementia, dementia biomarkers, biomarker diagnostics, early dementia detection, biomarkers for diseases, disease biomarkers, vocal biomarkers, biomarker detection, biomark diagnostics, schizophrenia biomarkers, biomarker companies, biomarkers company, biomarker company, biological markers for schizophrenia, biological markers of schizophrenia, biological markers of depression, biological markers of alzheimer's disease, biomarkers for persistent depressive disorder, biomarkers for psychiatric disorders, alzheimer's biomarkers, biomarkers in dementia, biomarkers for alzheimer's disease, biomarker diagnosis service, biomarker service,

EU MDR

Certified

biomarker analysis services, biomarker quantification, biomarkers in disease diagnosis, biomarker for alzheimer's disease, biomarker monitoring, biomarkers for early detection of alzheimer disease, biomarkers for diseases, sound biomarker, vocal biomarkers the future of diagnostic medicine,

ISO 13485

Certified

mental health ai, stress voice analysis, ai for mental health, mental health machine learning, machine learning mental health, mental health diagnostic software, mental health biomarkers, ai mental healthcare, mental health biomarker, voice mental health, artificial intelligence for mental health, voice biomarkers mental health, biomarkers for mental illness, ai psychiatry, ai and psychiatry,

ISO 27001

Compliant

alzheimer artificial intelligence, artificial intelligence alzheimer's, alzheimer's disease detection, detecting alzheimer's disease, dementia detection, predicting alzheimer's, alzheimer's disease artificial intelligence, machine learning alzheimer's disease, ai alzheimer's detection, vocal biomarkers alzheimer's, alzheimer's disease machine learning, audible disease dementia, vocal analysis software, biomark technologies,

GDPR & HIPAA

Compliant

LEADERSHIP TEAM

ai research in clinical trials, ai for medical research, ai research in healthcare, ai diagnosis in clinical trials, ai in diagnostics, ai clinical solutions, ai healthcare solutions, ai solutions in healthcare, ai technology in medicine, ai for healthcare solutions, ai in medicine research, healthcare ai solutions, medical diagnosis system in ai, disease diagnosis using ai, ai for early disease detection,

Mitja Alge

Co-Founder & Chief Data Scientist

ai in medicine, ai diagnosis, artificial intelligence medical diagnosis, ai medical diagnosis, ai medical, artificial intelligence medical, medical diagnosis ai, ai for medical diagnosis, ai medical research, artificial intelligence medical research, ai in clinical trial, ai in clinical trials, ai for clinical trials, ai disease diagnosis, ai disease detection, ai diagnostics, ai diagnosis healthcare, ai healthcare diagnosis, ai for medical, ai for mental health, ai and dementia, ai healthcare research, ai technology in medicine, ai in medical diagnostics, ai diagnosis in healthcare, ai to diagnose mental illness, ai assisted medical diagnosis, medical diagnosis using ai, ai to detect alzheimer's, ai dementia diagnosis, ai for dementia, ai to detect alzheimer's disease, ai mental healthcare, ai for early disease detection, ai in clinical research, ai for depression, ai and psychiatry, ai for medicine, ai research for clinical trials,

Dr. Laura Kütt

Chief Commercial Officer

cough drug, chronic cough, respiratory monitoring, respiration monitors, respiratory monitor, respiratory monitoring devices, respiratory sensors, respiratory monitoring system, non-invasive respiratory monitoring, respiratory function monitor, portable respiratory monitor, cough detection, peak cough flow meter, peak cough flow measurement, cough detector, cough intensity, cough pattern, cough recorder, cough recording, cough studies, ai cough monitor, continuous cough measurement, cough data, cough measurement, cough measurement device, cough measurement system, cough measuring device, cough monitor, cough monitoring device, cough monitoring system, cough peak flow measurement, cough profile, cough tracker, coughtracker, detect and quantify cough, remote patient monitoring copd, copd remote monitoring, copd home monitoring, copd remote patient monitoring,

Dr. Alexander Duschau-Wicke

Co-Founder & CEO

biomarkers depression, biomarker analysis, biomarkers in depression, biomarker depression, biomarkers analysis, biomarkers for depression, biomarkers of depression, depression biomarkers, depression biomarker, clinical biomarker, biomarker in medicine, biomarkers in medicine, biomarkers of dementia, biomarkers dementia, biomarkers for dementia, dementia biomarkers, biomarker diagnostics, early dementia detection, biomarkers for diseases, disease biomarkers, vocal biomarkers, biomarker detection, biomark diagnostics, schizophrenia biomarkers, biomarker companies, biomarkers company, biomarker company, biological markers for schizophrenia, biological markers of schizophrenia, biological markers of depression, biological markers of alzheimer's disease, biomarkers for persistent depressive disorder, biomarkers for psychiatric disorders, alzheimer's biomarkers, biomarkers in dementia, biomarkers for alzheimer's disease, biomarker diagnosis service, biomarker service,

Michael Häberli

Co-Founder & CFO

OUR LEGACY AND
INDUSTRY COMMITMENT

After careers in Pharma and MedTech, the co-founders were eager to drive innovation and help people rather than get slowed down by corporate structures. They joined Evoleen, an incubator partnering with health industry players, co-creating new ventures to accelerate innovation. After prototyping several digital health initiatives, they started the SIVA project in coordination with the global pharmaceutical company Bayer, which was developing a novel drug targeting refractory chronic cough. From the successful initial feasibility project findings, it became clear that the team was holding the keys to addressing many important unmet needs in the cough space. They co-founded SIVA Health and have been driving the vision of providing better lives for respiratory patients ever since.
 
After Bayer discontinued its refractory chronic cough drug development project, SIVA Health became fully independent and owns all generated IPs. Today, the team works with several leading global pharmaceutical companies to support their efforts to develop better treatment options for respiratory patients.

Do you want to help us enable patients worldwide to live better lives?
bottom of page